EICHORCondition: Non Small Cell Lung Cancer · Accupuncture · PD-1 Inhibitors · Sponsor: Guangzhou University of Traditional Chinese Medicine
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This multicentre, randomized controlled trial evaluates the effect and safety of acupuncture combing with PD-1 inhibitors plus chemotherapy in NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial four-six cycles of chemotherapy combined with PD-1 inhibitors.
This description comes directly from the study's public registry record.
Yanjuan Zhu, MD · 86 20 81887233 · zyjsophy@gzucm.edu.cn
Xiwu Rao, MD · 86 20 81887233 · 18851823395@163.com
Always discuss trial participation with your own doctor first.
| Guangdong Provincial Hospital of Chinese Medicine | Guangzhou, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Guangzhou University of Chinese Medicine | Guangzhou, Guangdong, China | Recruiting |
| Jiangsu Provincial Hospital of Chinese Medicine | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07337096